Penn State Hershey Melanoma and Skin Cancer Center
Melanoma is the leading cause of death from skin disease – and its rate of occurrence is steadily increasing. In America, one person dies of melanoma every hour. More than 60,000 new cases in the United States are diagnosed each year, and this number is growing at an alarming rate.
In an effort to fight this trend, Penn State Hershey Melanoma and Skin Cancer Center offers a multidisciplinary approach to developing new treatments for melanoma patients. The Melanoma and Skin Cancer Center convenes researchers and clinicians from surgery, dermatology, medical and radiation oncology, pharmacology, orthopedics and other areas with a goal of identifying and evaluating new agents and clinical interventions. Discoveries developed in the research portion of the Melanoma and Skin Cancer Center are tested through a portfolio of clinical trials offered to patients.
Click here to learn more about the next generation of therapies.
"Dead Wrong… It's Only Skin Cancer"
Dead Wrong… It's Only Skin Cancer was produced in 2008 by the Mike Geltrude Foundation of Nutley, NJ. However, this educational documentary is not about Mike Geltrude and his battle against melanoma. In reality, it's about you. The reason is that anyone at any age can be afflicted by this deadly disease and one of the greatest weapons we have to combat melanoma is education. Therefore, taking a half hour to watch this film may save your life and by spreading the word it can save countless lives. As the saying goes, "an ounce of prevention is better than a pound of cure." - Watch Video
- "Dear 16-year old me" (DCMF Canada) - Watch video
- "Myths and facts of Artificial Sun Tanning" - Watch Presentation
The Melanoma and Skin Cancer Center continues to facilitate phase I, II, and III clinical trials of new therapies in its quest to find a cure. Please contact us for information about current clinical trials.
The Melanoma and Skin Cancer Center Skin Oncology Program includes a multidisciplinary clinic for the treatment of melanoma. The Skin Oncology Program's goals include clinical care, research, education, and community outreach.
The Melanoma and Skin Cancer Center's research goal is to unravel the biology and signaling pathways involved in melanoma tumor development to develop the next generation of therapeutic agents to treat this disease.
For more information on the research and clinical activities of the Center, click here
As part of the Penn State Cancer Institute's and the Melanoma and Skin Cancer Center's ongoing efforts to advance and support translational research to find the cure, the Center announces the availability of funding to support projects. The funds available were raised through the Annual Chocolate Tour fundraising effort. For more information on the funds available and how to apply.
Melanoma and Skin Cancer Center Visiting Scholar Lectureship
2011: New Frontiers for Melanoma Centers: "Strategies for diagnosis, management and collaborative research
Presenter: Dr. John Thompson, M.D., Executive Director Melanoma Institute of Australia
2013: Medical Therapy of Melanoma: "Have we gone from zero to sixty?" (Watch presentation)
Presenter: Dr. Sanjiv S. Agarwala, M.D., Director, Melanoma and Immunotherapy Program, St. Luke's Hospital, Temple University
Presenter: Dr. John M. Kirkwood, M.D. Usher Professor of Medicine, Dermatology, and translational Science, Univeristy of Pittsburgh School of Medicine and Director, Melanoma and Skin Cancer Program, Univeristy of Pittsburgh Cancer Institute Hillman Cancer Center.
- The Medical Minute: Good sun protection comes in many forms Just as most people know there is no such thing as safe smoking, there is also no such thing as safe sunbathing or tanning. Exposure to UVA and UVB rays can cause more than just a sunburn or tan – it can lead to everything from wrinkles to skin cancer.More...
- Type 2 diabetes drug trials unnecessarily exclude women While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.More...
- Transition underway to new University Technology Center A new data center providing centralized, secure space for patient, research and educational data from Penn State Health Milton S. Hershey Medical Center and Penn State College of Medicine is now online. Officials gathered May 4 to dedicate the 46,000-square-foot University Technology Center.More...
- Eta Chapter of Alpha Omega Alpha inducts 30 new members The Penn State Eta Chapter of Alpha Omega Alpha recently inducted 30 new members.More...